Maximus: Up on Q2 revenue beat, strong forecast

Maximus

06/05/2021 15:05

** Shares of healthcare service provider  MMS.N  up 1% at
$93.2 in early trading after Q2 revenue tops estimates 
    ** MMS expects FY revenue to be in the range of $4 bln to
$4.2 bln, above analysts' estimates of $3.63 bln
    ** Says revenue was boosted by COVID-19 response work,
including vaccination distribution support services, disease
investigation, contact tracing and other key initiatives 
 urn:newsml:reuters.com:*:nBwQhKfYa
    ** Stock up ~26% YTD

 (Reporting by Sahil Shaw in Bengaluru)
 ((sahil.shaw@thomsonreuters.com))